Rare diseases
Investigational molecules
Locations
Study on the Safety and Effects of XL092 with Nivolumab, Ipilimumab, and Relatlimab for Patients with Advanced Solid Tumors
AustriaStudy of Zenocutuzumab for Patients with Solid Tumors with NRG1 Fusion
AustriaStudy on Cabozantinib and Drug Combination for Untreated Metastatic Renal Cell Carcinoma in Intermediate and Poor Risk Patients
AustriaStudy on the Safety and Tolerability of STK-002 for Patients with Autosomal Dominant Optic Atrophy
AustriaStudy on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients
AustriaStudy on the Safety and Effectiveness of Baricitinib for Children Aged 1 to 17 with Juvenile Idiopathic Arthritis
AustriaStudy on Long-Term Safety of Enzalutamide, Abiraterone, and Prednisolone for Patients with Prostate Cancer from Previous Enzalutamide Trials
AustriaStudy on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase
AustriaStudy on the Safety and Effectiveness of TransCon CNP for Infants with Achondroplasia
AustriaStudy on Maximizing Methotrexate Therapy for Patients with Active Rheumatoid Arthritis
AustriaStudy on Diacerein 1% Ointment for Treating Generalized Epidermolysis Bullosa Simplex in Patients Aged 6 Months and Older
AustriaStudy Comparing Pirtobrutinib and Ibrutinib for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
